Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaut Barnoud

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cell Death & Disease|April 24, 2026
CK1α agonists attenuate medulloblastoma stemness and relapse riskKendell Peterson, Maria Turos-Cabal, Pritika Shahani, et al.
Cell Death and Differentiation|May 27, 2024
HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancerGiulia D S Ferretti, Colleen E Quaas, Irene Bertolini, et al.
Cancer Research|October 7, 2020
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in TumorsThibaut Barnoud, Jessica C Leung, Julia I-Ju Leu, et al.
Cancer Discovery|May 4, 2023
An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor SuppressionAlexandra Indeglia, Jessica C Leung, Sven A Miller, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Cancer Research|July 18, 2020
A Rare <i>TP53</i> Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple CancersJacquelyn Powers, Emilia M Pinto, Thibaut Barnoud, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cell Death & Disease|April 24, 2026
CK1α agonists attenuate medulloblastoma stemness and relapse riskKendell Peterson, Maria Turos-Cabal, Pritika Shahani, et al.
Cell Death and Differentiation|May 27, 2024
HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancerGiulia D S Ferretti, Colleen E Quaas, Irene Bertolini, et al.
Cancer Research|October 7, 2020
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in TumorsThibaut Barnoud, Jessica C Leung, Julia I-Ju Leu, et al.
Cancer Discovery|May 4, 2023
An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor SuppressionAlexandra Indeglia, Jessica C Leung, Sven A Miller, et al.
The Journal of Clinical Investigation|June 17, 2024
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical modelsJezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, et al.
Cancer Research|July 18, 2020
A Rare <i>TP53</i> Mutation Predominant in Ashkenazi Jews Confers Risk of Multiple CancersJacquelyn Powers, Emilia M Pinto, Thibaut Barnoud, et al.
Pageof 4